WallStreetZenWallStreetZen

AnalystsTessa Romero
Tessa Romero's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 17%
#737 out of 4555 analysts
Average Return
+7.94%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good

Tessa Romero's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Biohaven LtdBHVN
+174.33%$14.65$40.19
2023-01-03 -
2024-01-03
Strong Buy
Dyne Therapeutics IncDYN
+125.52%$10.58$23.86
2023-08-08 -
2024-04-19
Strong Buy
Edgewise Therapeutics IncEWTX
+96.52%$7.75$15.23
2023-06-29 -
2024-04-19
Strong Buy
Biohaven LtdBHVN
+96.13%$19.88$38.99
2023-08-15 -
2024-04-19
Strong Buy
Cytokinetics IncCYTK
+92.02%$35.20$67.59
2023-03-19 -
2024-03-19
Strong Buy

Tessa Romero Analyst Color

Get additional color on Tessa Romero's coverage of popular stocks

Tessa Romero's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Acadia Pharmaceuticals IncACAD
4Strong Buy$25.00+48.63%Maintains
a month ago
Neumora Therapeutics IncNMRA
3Strong Buy$22.00+116.11%Maintains
a month ago
Cytokinetics IncCYTK
2Strong Buy$77.00+13.99%Maintains
a month ago
Agios Pharmaceuticals IncAGIO
3Hold$30.00+1.59%Maintains
2 months ago
Biohaven LtdBHVN
4Strong Buy$56.00+43.63%Maintains
2 months ago
Eyepoint Pharmaceuticals IncEYPT
1Strong Buy$35.00+98.30%Initiates Coverage On
3 months ago
Lexeo Therapeutics IncLXEO
1Strong Buy$20.00+65.98%Initiates Coverage On
5 months ago
Y Mabs Therapeutics IncYMAB
5Strong Sell$7.00-53.73%Maintains
8 months ago
Dyne Therapeutics IncDYN
2Strong Buy$22.00-7.80%Maintains
8 months ago
Edgewise Therapeutics IncEWTX
6Strong Buy$25.00+64.15%Maintains
10 months ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$55.00+37.91%Maintains
a year ago
Seres Therapeutics IncMCRB
1Hold$7.00+1,150.00%Initiates Coverage On
a year ago
Scholar Rock Holding CorpSRRK
2Strong Buy$20.00N/AMaintains
a year ago
Global Blood Therapeutics IncGBT
2Hold$36.00N/AMaintains
2 years ago
Orchard Therapeutics PLCORTX
1Strong Buy$150.00N/AAssumes
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.